ADMA Biologics Inc (ADMA) Q3 2024 Earnings Call Highlights: Record Revenue and Net Income Surge [Yahoo! Finance]
ADMA Biologics Inc (ADMA)
Last adma biologics inc earnings: 3/12 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.admabiologics.com
Company Research
Source: Yahoo! Finance
Net Income: $35.9 million, a 1,300% increase year-over-year. Gross Margin: 50% for the third quarter of 2024, compared to 37% in the third quarter of 2023. Operating Cash Flow: $25 million generated during the third quarter. Net Leverage Ratio: Improved to approximately 0.1x, annualizing the third quarter results. Warning! GuruFocus has detected 6 Warning Sign with ADMA. Release Date: November 07, 2024 For the complete transcript of the earnings call, please refer to the full earnings call transcript ADMA Biologics Inc ( NASDAQ:ADMA ) reported a significant increase in total revenues, reaching $119.8 million, a 78% year-over-year growth. The company achieved a remarkable 256% growth in adjusted EBITDA, reaching $45.4 million. Net income saw an impressive increase of 1,300% year-over-year, amounting to $35.9 million. ADMA Biologics Inc ( NASDAQ:ADMA ) raised its financial guidance for 2024 and 2025, expecting total revenues to exceed $415 million and $465 million,
Show less
Read more
Impact Snapshot
Event Time:
ADMA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ADMA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ADMA alerts
High impacting ADMA Biologics Inc news events
Weekly update
A roundup of the hottest topics
ADMA
News
- ADMA BIOLOGICS ALERT: Bragar Eagel & Squire, P.C. is Investigating ADMA Biologics, Inc. on Behalf of ADMA Biologics Stockholders and Encourages Investors to Contact the FirmGlobeNewswire
- SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMAAccesswire
- ADMA Biologics, Inc. Is Being Investigated For Fraud And Affected Investors Are Urged To Contact The Schall Law Firm Accesswire
- The Schall Law Firm Wants Shareholders To Take Part In An Inquiry Launched Into ADMA Biologics Inc For Securities Law ViolationsAccesswire
- ADMA Biologics, Inc. Is Being Investigated For Defrauding Investors And Those With Losses Are Urged To Reach Out To The Schall Law FirmAccesswire
ADMA
Earnings
- 11/7/24 - Beat
ADMA
Sec Filings
- 11/12/24 - Form SC
- 11/8/24 - Form SC
- 11/7/24 - Form 10-Q
- ADMA's page on the SEC website